2000-Year of the Biotechs! | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
2000-Year of the Biotechs!

An SI Board Since December 1999

Posts	SubjectMarks	Bans
1142	41	0

Emcee: Arthur Radley	Type: Unmoderated

Introduction Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
992	<b>MOTOROLA AND ICONIX ESTABLISH PARTNERSHIP TO ACCELERATE DEVELOPMENT O	opalapril	-	8/11/2000
991	MM, Don't know who keeps selling GZMO, but its ok with me as I keep buying	smh	-	8/11/2000
990	So long as it's not on margin, all you need is patience. nig	nigel bates	-	8/11/2000
989	Well the VICL flip worked once again, so I'm winning the battles but losing	Mike McFarland	-	8/11/2000
988	worldlyinvestor on Onyx biz.yahoo.com Only noticed it today because of the vicl	Mike McFarland	-	8/10/2000
987	Gee, that is a happy little coincidence, and a nice little pop today. I wonder i	Mike McFarland	-	8/10/2000
986	<b>Procyon Biopharma Inc</b> Hello everyone,if you want to seeProcy	thebeach	-	8/10/2000
985	CORX news...http://biz.yahoo.com/prnews/000809/ca_donner_.html	Arthur Radley	-	8/9/2000
984	<b> Flamel Hires Yale Mouthpiece</b> biz.yahoo.com	opalapril	-	8/9/2000
983	I can't put my hand on it at this moment, but the other day I saw a recent c	opalapril	-	8/8/2000
982	Opal, Earnings out on CSON. What is your take on the reduced revenue numbers? Is	Arthur Radley	-	8/8/2000
981	Have taken profits now in PGNX after quite a nice run up these past few days, a	Mike McFarland	-	8/8/2000
980	ONYX-015 works in the following way - wildtype adenovirus will enter a cell and,	scott_jiminez	-	8/8/2000
979	Hi opalapril, ONXX is risky, but I value French Anderson's opinion as he is	SnowShredder	-	8/8/2000
978	Worth noting: Over the last ten days Isis Pharmaceutical (ISIP), a pioneer in st	opalapril	-	8/7/2000
977	Just got back from a long errand. Had I been free earlier I would have loaded up	opalapril	-	8/7/2000
976	Had to make a decision this morning between CSON and INKP. Had done more DD on I	Arthur Radley	-	8/7/2000
975	Opal, If you get your vaccination shots, and then venture over to Yahoo! you wil	Arthur Radley	-	8/6/2000
974	A $100 billion dollar market....as Everett Dirksen once said..."a few milli	Arthur Radley	-	8/6/2000
973	Last week ended as a good one for biotechnology stocks.The BioBizNet Select Inde	blackmerlin	-	8/6/2000
972	Friday: August 11 - Surgical Biomaterials 2000 Conference Sponsored by Stephe	opalapril	-	8/6/2000
971	Thanks for the additional info on TXB. I always like to see that volume creeping	Arthur Radley	-	8/4/2000
970	No hype - just sharing a thought: TXB. At long last it looks like TXB is begin	opalapril	-	8/3/2000
969	Vical Releases Allovectin-7 Results At International Head and Neck Cancer Confer	Mike McFarland	-	8/1/2000
968	ONXX is interesting, but IMO still a risky investment. Remember: (1) On the fi	opalapril	-	8/1/2000

Go to reply# or date (mm/dd/yy):